Display options
Cite
Dooley K, Sullivan JA. Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?. Health Care Law Mon. 2010;2010(10):2-8
Dooley, K., & Sullivan, J. A. (2010). Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?. Health care law monthly, 2010(10), 2-8.
Dooley, Kathleen, and Sullivan, Julie Ann. "Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?." Health care law monthly vol. 2010,10 (2010): 2-8.
Dooley K, Sullivan JA. Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?. Health Care Law Mon. 2010 Oct;2010(10):2-8. PMID: 21302589.
Copy Download .nbib Format: NLM
Share it on

Health Care Law Mon. 2010 Oct;2010(10):2-8.

Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?.

Health care law monthly

Kathleen Dooley, Julie Ann Sullivan

Affiliations

  1. McGuireWoods LLP, Charlotte, North Carolina, USA. [email protected]

PMID: 21302589

[No abstract available.]

Substances

MeSH terms

Publication Types